Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
AMRX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.01B
Close$
$9.88
54.5% downside
Current Fair Value
54.5% downsideOvervalued by 54.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.01 Billion |
|---|---|
| Enterprise Value | $10.14 Billion |
| Earnings per Share | $0.23 |
| Beta | 1.25 |
| Outstanding Shares | 335,733,000 |
Return
| Return on Equity | 13.09% |
|---|---|
| Return on Assets | 1.32% |
| Return on Invested Capital | -3.48% |
Valuation & Multiples
| P/E Ratio | 46.84 |
|---|---|
| PEG | -33.19 |
| Price to Sales | 3.1 |
| Price to Book Ratio | 21.71 |
| Enterprise Value to Revenue | 4.1 |
| Enterprise Value to EBIT | -70.33 |
| Enterprise Value to Net Income | 145 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 6.18 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS
$0.26
Est. $0.24Revenue
$862.68 M
Est. $817.77 MNext Earnings Call
Expected Date
February 26, 2027
EPS Estimate
$0.24
Consensus analyst estimateRevenue Estimate
$838.21 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.25%▼ 42.06% |
|---|---|
| Total Invested | $528.83M▼ 81.51% |
| Investors Holding | 141▼ 174.00% |